English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  De novo fragment-based design of inhibitors of DXS guided by spin-diffusion-based NMR spectroscopy.

Masini, T., Pilger, J., Kroezen, B. S., Illarionov, B., Lottmann, P., Fischer, M., et al. (2014). De novo fragment-based design of inhibitors of DXS guided by spin-diffusion-based NMR spectroscopy. Chemical Science, 5(9), 3543-3551. doi:10.1039/C4SC00588K.

Item is

Files

show Files
hide Files
:
2057350.pdf (Publisher version), 903KB
Name:
2057350.pdf
Description:
-
OA-Status:
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-
:
2057350_Suppl.pdf.part (Supplementary material), 708KB
Name:
2057350_Suppl.pdf.part
Description:
-
OA-Status:
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-

Locators

show
hide
Description:
-
OA-Status:

Creators

show
hide
 Creators:
Masini, T., Author
Pilger, J.1, Author           
Kroezen, B. S., Author
Illarionov, B., Author
Lottmann, P.1, Author           
Fischer, M., Author
Griesinger, C.1, Author                 
Hirsch, A. K. H., Author
Affiliations:
1Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society, ou_578567              

Content

show
hide
Free keywords: -
 Abstract: We applied for the first time an innovative ligand-based NMR methodology (STI) to a medicinal-chemistry project aimed at the development of inhibitors for the enzyme 1-deoxy-D-xylulose-5-phosphate synthase (DXS). DXS is the first enzyme of the 2C-methyl-D-erythritol-4-phosphate (MEP) pathway, present in most bacteria (and not in humans) and responsible for the synthesis of the essential isoprenoid precursors. We designed de novo a first generation of fragments, using Deinococcus radiodurans DXS as a model enzyme, targeting the thiamine diphosphate (TDP) pocket of DXS whilst also exploring the putative substrate-binding pocket, where selectivity over other human TDP-dependent enzymes could be gained. The STI methodology – suitable for weak binders – was essential to determine the binding mode in solution of one of the fragments, circumventing the requirement for an X-ray co-crystal structure, which is known to be particularly challenging for this specific enzyme and in general for weak binders. Based on this finding, we carried out fragment growing and optimisation, which led to a three-fold more potent fragment, about as potent as the well-established thiamine analogue deazathiamine. The STI methodology proved therefore its strong potential as a tool to support medicinal-chemistry projects in their early stages, especially when dealing with weak binders.

Details

show
hide
Language(s): eng - English
 Dates: 2014-06-122014-09
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1039/C4SC00588K
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Chemical Science
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 5 (9) Sequence Number: - Start / End Page: 3543 - 3551 Identifier: -